Chairman
Roberto Valenti
DLA Piper Studio Legale Tributario Associato
President
Federico Viganò
Country Manager - Vertex pharmaceutical
Topics Covered
The Life Sciences Committee consists of a Technical Group and a Strategic Group, focusing on topics of interest to businesses in the sector. The agenda will integrate technical assessments of regulatory and other developments with the priorities identified by the Strategic Committee to address key challenges and promote sector growth.
Next Steps
Operational priorities will be defined in line with emerging inputs from both groups, and thematic working groups will be initiated. The focus will be on developing concrete proposals to support companies in the Life Sciences sector.
